Novo Nordisk Acquires Catalent's Production Sites in Strategic Expansion
Deal News | Jan 13, 2025 | Legal Community Italy
Novo Nordisk, a pharmaceutical company owned by the life sciences investment firm Novo Holdings, has acquired three manufacturing facilities from Catalent, also previously acquired by Novo Holdings. These sites are located in Anagni, Italy; Bloomington, Indiana, USA; and Brussels, Belgium. The legal aspects of the transaction were managed by several law firms. BonelliErede assisted Novo Nordisk in Italy, with a team focusing on golden power and corporate aspects. Linklaters supported Novo Holdings with merger control and golden power aspects internationally, while PedersoliGattai assisted Catalent on the Italian side. The acquisition highlights Novo Nordisk's strategy to enhance manufacturing capabilities and geographic reach.
Sectors
- Pharmaceutical
- Life Sciences Investment
- Legal Services
Geography
- Italy – One of the acquired manufacturing sites is in Anagni, Italy, and Italian legal aspects were handled by BonelliErede.
- United States – One of the acquired manufacturing sites is in Bloomington, Indiana, USA.
- Belgium – One of the acquired manufacturing sites is in Brussels, Belgium.
Industry
- Pharmaceutical – The acquisition involves Novo Nordisk, a pharmaceutical company, expanding its manufacturing capabilities.
- Life Sciences Investment – Novo Holdings, which owns Novo Nordisk, is an investment firm focused on the life sciences sector.
- Legal Services – Several legal firms were involved in facilitating the acquisition process in various jurisdictions.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Novo Nordisk | Buyer | Company | A pharmaceutical company controlled by Novo Holdings. |
| Catalent | Target | Company | A company whose manufacturing facilities were acquired by Novo Nordisk. |
| Novo Holdings | PE Firm | Company | An investment firm focused on life sciences, owning Novo Nordisk. |
| BonelliErede | Legal Advisor | Company | Provided legal assistance to Novo Nordisk for Italian aspects of the transaction. |
| Linklaters | Legal Advisor | Company | Assisted Novo Holdings with merger control and foreign investment aspects. |
| PedersoliGattai | Legal Advisor | Company | Provided legal support to Catalent for the Italian aspects of the deal. |